|
000
| 02178cam 2200385zi 4500 |
|---|
| 001 | 9.894085 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107173632 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 201126t20202020onc o f000 0 eng d |
|---|
| 020 | |a9780660367569 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-304/2020E-PDF |
|---|
| 245 | 00|aGuidance document : |binterim compliance approach regarding donor ova processed prior to February 4, 2020. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (8 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |a"Publication date: December 18, 2020." |
|---|
| 500 | |a"Effective date: 2020-12-18." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : approche de conformité intérimaire concernant les ovules de donneurs traités avant le 4 février 2020. |
|---|
| 520 | |a"Health Canada is notifying establishments and health professionals who process, import, distribute and/or make use of donor ova for the purpose of assisted human reproduction (AHR) of its interim compliance approach with respect to the processing requirements for donor ova that were obtained prior to the Safety of Sperm and Ova Regulations (Safety Regulations) coming into force on February 4, 2020 (“pre-CIF donor ova”)"--Introduction, page 4. |
|---|
| 650 | 0|aHuman reproductive technology|xLaw and legislation|zCanada. |
|---|
| 650 | 0|aSpermatozoa|xSafety measures. |
|---|
| 650 | 0|aOvum|xSafety measures. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.894087 |
|---|
| 856 | 40|qPDF|s250 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H164-304-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/assisted-human-reproduction/interim-compliance-approach-donor-ova-prior-february-4-2020.html |
|---|